ADMA in the 13F filings
Adma Biologics Inc · CUSIP 000899104
- Quarter end
- 30 Jun 2025
- the date the book describes
- Filed
- 15 Aug 2025
- latest of these filings; the earliest 13 Aug 2025
- Managers listing it
- 6
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q1 2025 and Q2 2025; 4 listed it in both
- Shares listed
- 4,825,367
- combined, among listed positions
- Reported value
- $88m
- combined, at the quarter end
Among the 95 comparable managers: 3 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing ADMA in Q2 2025
6 of 6 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | 3,146,053 | $57m | 0.08% | Trimmed | -402,935 | 13 Aug 2025 (the filing on sec.gov) |
| Two Sigma Advisers LP | 1,033,400 | $19m | under 0.1% | Trimmed | -1,553,200 | 14 Aug 2025 (the filing on sec.gov) |
| ExodusPoint Capital Management LP | 309,021 | $5.6m | under 0.1% | New | new | 13 Aug 2025 (the filing on sec.gov) |
| Winton Group Ltd | 272,817 | $5.0m | 0.25% | Added | +205,094 | 14 Aug 2025 (the filing on sec.gov) |
| Caxton Associates LLP | 33,664 | $613k | under 0.1% | Held | 0 | 15 Aug 2025 (the filing on sec.gov) |
| Polen Capital Management LLC | 30,412 | $554k | under 0.1% | New | new | 13 Aug 2025 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- ExodusPoint Capital Management LPnew position · 309,021 shares now+309,021
- Winton Group Ltdexisting position · 272,817 shares now+205,094
- Polen Capital Management LLCnew position · 30,412 shares now+30,412
Reductions
- Two Sigma Advisers LPexisting position · 1,033,400 shares now-1,553,200
- Renaissance Technologies LLCexisting position · 3,146,053 shares now-402,935
New positions and exits
New (2)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2019 | 1 | $8.4m | n.a. | n.a. |
| Q3 2019 | 1 | $7.0m | n.a. | n.a. |
| Q4 2019 | 1 | $5.0m | n.a. | n.a. |
| Q1 2020 | 1 | $2.1m | n.a. | n.a. |
| Q2 2020 | 2 | $2.4m | n.a. | n.a. |
| Q3 2020 | 2 | $6.2m | n.a. | n.a. |
| Q1 2022 | 1 | $4.2m | n.a. | n.a. |
| Q2 2022 | 1 | $4.3m | n.a. | n.a. |
| Q3 2022 | 1 | $4.9m | n.a. | n.a. |
| Q4 2022 | 2 | $7.4m | n.a. | n.a. |
| Q1 2023 | 1 | $678k | n.a. | n.a. |
| Q2 2023 | 2 | $11m | n.a. | n.a. |
| Q3 2023 | 1 | $11m | n.a. | n.a. |
| Q4 2023 | 2 | $13m | 1 | 1 |
| Q1 2024 | 4 | $62m | 4 | 0 |
| Q2 2024 | 6 | $225m | 5 | 1 |
| Q3 2024 | 8 | $378m | 4 | 4 |
| Q4 2024 | 7 | $209m | 3 | 3 |
| Q1 2025 | 7 | $187m | 3 | 4 |
| Q2 2025 | 6 | $88m | 3 | 2 |
| Q3 2025 | 4 | $221m | 2 | 3 |
| Q4 2025 | 8 | $464m | 16 | 17 |
| Q1 2026 | 3 | $106m | 22 | 9 |
| Q2 2026 | 1 | $73m | 10 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ADMA and GILD →ADMA and AMGN →ADMA and ARGX →Choose a stock to compare with ADMA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ADMA, latest filings →Back to the 13F Explorer →